This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Inflazome Limited. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovations of Daniel Schwizer
Introduction
Daniel Schwizer is a notable inventor based in Bubendorf, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical treatment.
Latest Patents
Daniel Schwizer holds a patent for a process related to the preparation of N-((1,2,3,4,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-iso-propyl-1H-pyrazole-3-sulfonamide and its salts. This invention is particularly relevant for its applications in pharmaceutical compositions aimed at treating and preventing various medical disorders, especially through NLRP3 inhibition.
Career Highlights
Daniel Schwizer is associated with Inflazome Limited, a company focused on developing innovative therapies for inflammatory diseases. His work has been instrumental in advancing the understanding and treatment of conditions that involve the NLRP3 inflammasome.
Collaborations
Daniel has collaborated with notable colleagues, including Sascha Breeger and Stephen Thom, who share a commitment to advancing pharmaceutical research and development.
Conclusion
Daniel Schwizer's contributions to the field of pharmaceuticals through his innovative patent and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile